Changmao Biochemical Engineering Dividends and Buybacks
Dividend criteria checks 0/6
Changmao Biochemical Engineering does not currently pay a dividend.
Key information
0%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | HK$0.0879 |
| Payout ratio | 0% |
Recent dividend and buyback updates
Recent updates
Further Upside For Changmao Biochemical Engineering Company Limited (HKG:954) Shares Could Introduce Price Risks After 25% Bounce
Sep 23
Investors Will Want Changmao Biochemical Engineering's (HKG:954) Growth In ROCE To Persist
Aug 02Returns On Capital At Changmao Biochemical Engineering (HKG:954) Have Stalled
Nov 18We Believe Changmao Biochemical Engineering's (HKG:954) Earnings Are A Poor Guide For Its Profitability
Apr 28Changmao Biochemical Engineering (HKG:954) Will Be Looking To Turn Around Its Returns
Aug 03Changmao Biochemical Engineering (HKG:954) May Have Issues Allocating Its Capital
May 04Tread With Caution Around Changmao Biochemical Engineering Company Limited's (HKG:954) 8.8% Dividend Yield
Feb 23Will Changmao Biochemical Engineering (HKG:954) Multiply In Value Going Forward?
Jan 26
A Quick Analysis On Changmao Biochemical Engineering's (HKG:954) CEO Salary
Dec 02Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 954's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 954's dividend payments have been increasing.
Dividend Yield vs Market
| Changmao Biochemical Engineering Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (954) | 0% |
| Market Bottom 25% (HK) | 3.2% |
| Market Top 25% (HK) | 8.1% |
| Industry Average (Chemicals) | 5.2% |
| Analyst forecast (954) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate 954's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 954's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: 954 is not paying a notable dividend for the Hong Kong market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 954 has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 03:33 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Changmao Biochemical Engineering Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|